The role of biopsy for small renal masses
详细信息 查看全文
- 作者：Ricardo R.N. Leã ; o<sup>1sup> ; Patrick O. Richard<sup> ; sup><sup>1sup><sup> ; sup><sup>patrick.richard@uhn.casup> ; Michael A.S. Jewett
- 关键词：Kidney cancer ; Renal cell carcinoma ; Renal tumour biopsy ; Small renal masses
- 刊名：International Journal of Surgery
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：36
- 期：part_PC
- 页码：513-517
- 全文大小：260 K
- 卷排序：36
文摘
Small renal masses (SRMs) are defined as enhancing kidney tumours ≤4 cm that are usually incidentally detected. Most, but not all, are RCCs.. SRMs are usually treated as presumed RCC. As a result, benign tumours and low grade RCCs of uncertain biology are being treated in over 20% of cases. Pretreatment renal tumour biopsy (RTB) can reduce potentially unnecessary treatment, but is not widely practiced yet. RTB is safe, with only a 1% incidence of significant complications, has a high diagnostic yield and accuracy, and is cost effective. RTB, together with molecular and genetic studies will improve our knowledge of SRMs and has the potential of risk-adapted personalized treatment